These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 4027301
21. Effects of adrenaline administration on platelet MAO of anxious and normal subjects. Kralik PM, Ho BT, Mathew RJ, Taylor DL, Weinman ML. Neuropsychobiology; 1982; 8(4):205-9. PubMed ID: 7133369 [No Abstract] [Full Text] [Related]
22. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D. J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907 [Abstract] [Full Text] [Related]
23. Plasma lipid levels in patients with panic disorder or agoraphobia. Hayward C, Taylor CB, Roth WT, King R, Agras WS. Am J Psychiatry; 1989 Jul; 146(7):917-9. PubMed ID: 2742017 [Abstract] [Full Text] [Related]
24. Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Stein MB, Uhde TW. Biol Psychiatry; 1988 Jul; 24(3):322-30. PubMed ID: 2840978 [Abstract] [Full Text] [Related]
25. A 3H-flunitrazepam binding inhibitor is present in psychiatric patients' sera. Marazziti D, Pietrini P, Martini C, Giannaccini G, Perugi G, Placidi GF, Cassano GB, Lucacchini A. Neuropsychobiology; 1987 Jul; 18(2):74-6. PubMed ID: 2836759 [Abstract] [Full Text] [Related]
26. Thyroid hormones in panic disorder, panic disorder with agoraphobia, and generalized anxiety disorder. Munjack DJ, Palmer R. J Clin Psychiatry; 1988 Jun; 49(6):229-31. PubMed ID: 3379028 [Abstract] [Full Text] [Related]
27. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Schatzberg AF, Rothschild AJ, Langlais PJ, Lerbinger JE, Schildkraut JJ, Cole JO. Psychiatry Res; 1987 Feb; 20(2):155-64. PubMed ID: 3575560 [Abstract] [Full Text] [Related]
30. Serotonin uptake in panic disorder and agoraphobia. Pecknold JC, Suranyi-Cadotte B, Chang H, Nair NP. Neuropsychopharmacology; 1988 May; 1(2):173-6. PubMed ID: 3251498 [Abstract] [Full Text] [Related]
31. Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology. Whitfield JB, Pang D, Bucholz KK, Madden PA, Heath AC, Statham DJ, Martin NG. Psychol Med; 2000 Mar; 30(2):443-54. PubMed ID: 10824664 [Abstract] [Full Text] [Related]
32. The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks. Grunhaus L, Tiongco D, Haskett RF, Greden JF. Biol Psychiatry; 1987 Apr; 22(4):517-21. PubMed ID: 3567265 [No Abstract] [Full Text] [Related]
33. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study. Maj M, Ariano MG, Arena F, Kemali D. Neuropsychobiology; 1984 Apr; 11(3):168-73. PubMed ID: 6089030 [Abstract] [Full Text] [Related]
34. High-affinity platelet [3H]LSD binding is decreased in panic disorder. Norman TR, Judd FK, Staikos V, Burrows GD, McIntyre IM. J Affect Disord; 1990 Jun; 19(2):119-23. PubMed ID: 2142698 [Abstract] [Full Text] [Related]
35. Basal adrenocortical activity and DST in electrodermally differentiated subgroups of panic patients. Kopp MS, Arató M, Magyar I, Buza K. Int J Psychophysiol; 1989 Mar; 7(1):77-83. PubMed ID: 2925467 [Abstract] [Full Text] [Related]
39. Relationship of platelet MAO activity to characteristics of major depressive illness. Georgotas A, McCue RE, Friedman E, Hapworth WE, Kim OM, Cooper TB, Chang I, Stokes PE. Psychiatry Res; 1986 Dec; 19(4):247-56. PubMed ID: 3809323 [Abstract] [Full Text] [Related]